Petlife Pharmaceuticals, Inc. (PTLF)

Petlife Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Feb 28, 2018	Aug 31, 2017	Aug 31, 2016	Aug 31, 2015	Aug 31, 2014	Aug 31, 2013
Net Income	-3.71	-23.26	-3.69	-1.93	-1.51	-0
Other Amortization	0.1	0.01	-	-	-	-
Asset Writedown & Restructuring Costs	0.27	0.27	0	-	-	-
Stock-Based Compensation	1.78	21.67	0.74	1.55	1.24	0
Provision & Write-off of Bad Debts	-	-	0	-	-	-
Other Operating Activities	0.88	0.54	-	-	-	-
Change in Accounts Payable	0.2	0.44	0.48	0.36	-	-
Change in Other Net Operating Assets	0.22	0.01	2.32	-	-	-
Operating Cash Flow	-0.26	-0.32	-0.15	-0.02	-0.27	-
Capital Expenditures	-	-	-	-0	-	-
Cash Acquisitions	-	-	-	-	0.1	-
Investing Cash Flow	-	-	-	-0	0.1	-
Short-Term Debt Issued	-	0.41	0.15	0.01	-	-
Total Debt Issued	0.34	0.41	0.15	0.01	-	-
Short-Term Debt Repaid	-	-0.03	-	-	-	-
Total Debt Repaid	-0.07	-0.03	-	-	-	-
Net Debt Issued (Repaid)	0.27	0.37	0.15	0.01	-	-
Issuance of Common Stock	-	-	-	-	0.18	-
Other Financing Activities	-	-	-	0.01	-0.01	-
Financing Cash Flow	0.27	0.37	0.15	0.02	0.17	-
Net Cash Flow	0.01	0.05	0	-0.01	0.01	-
Free Cash Flow	-0.26	-0.32	-0.15	-0.02	-0.27	-
Free Cash Flow Per Share	-0.00	-0.01	-0.02	-0.00	-0.03	-
Levered Free Cash Flow	0.73	5.07	3.47	-	-	-
Unlevered Free Cash Flow	0.94	5.3	3.47	-	-	-
Change in Net Working Capital	-0.67	2.36	-2.73	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.